BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33421557)

  • 1. Combining Clinical and Dosimetric Features in a PBS Proton Therapy Cohort to Develop a NTCP Model for Radiation-Induced Optic Neuropathy.
    Köthe A; van Luijk P; Safai S; Kountouri M; Lomax AJ; Weber DC; Fattori G
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):587-595. PubMed ID: 33421557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation-induced optic neuropathy after pencil beam scanning proton therapy for skull-base and head and neck tumours.
    Kountouri M; Pica A; Walser M; Albertini F; Bolsi A; Kliebsch U; Bachtiary B; Combescure C; Lomax AJ; Schneider R; Weber DC
    Br J Radiol; 2020 Mar; 93(1107):20190028. PubMed ID: 31322969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves.
    Demizu Y; Murakami M; Miyawaki D; Niwa Y; Akagi T; Sasaki R; Terashima K; Suga D; Kamae I; Hishikawa Y
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1487-92. PubMed ID: 19345516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation tolerance of the optic pathway in patients treated with proton and photon radiotherapy.
    Li PC; Liebsch NJ; Niemierko A; Giantsoudi D; Lessell S; Fullerton BC; Adams J; Shih HA
    Radiother Oncol; 2019 Feb; 131():112-119. PubMed ID: 30773177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways.
    Milano MT; Grimm J; Soltys SG; Yorke E; Moiseenko V; Tomé WA; Sahgal A; Xue J; Ma L; Solberg TD; Kirkpatrick JP; Constine LS; Flickinger JC; Marks LB; El Naqa I
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):87-99. PubMed ID: 29534899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for radiation-induced optic neuropathy: a case-control study.
    Ferguson I; Huecker J; Huang J; McClelland C; Van Stavern G
    Clin Exp Ophthalmol; 2017 Aug; 45(6):592-597. PubMed ID: 28181362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT).
    Brecht S; Boda-Heggemann J; Budjan J; Siebenlist K; Stieler F; Steil V; Wenz F; Lohr F; Buergy D
    Radiother Oncol; 2019 May; 134():166-177. PubMed ID: 31005211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTCP Modeling for High-Grade Temporal Radionecroses in a Large Cohort of Patients Receiving Pencil Beam Scanning Proton Therapy for Skull Base and Head and Neck Tumors.
    Schröder C; Köthe A; De Angelis C; Basler L; Fattori G; Safai S; Leiser D; Lomax AJ; Weber DC
    Int J Radiat Oncol Biol Phys; 2022 Jun; 113(2):448-455. PubMed ID: 35124132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation induced optic neuropathy: Does treatment modality influence the risk?
    Mohamed Ali A; Mathis T; Bensadoun RJ; Thariat J
    Bull Cancer; 2019 Dec; 106(12):1160-1176. PubMed ID: 31757405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does altered fractionation influence the risk of radiation-induced optic neuropathy?
    Bhandare N; Monroe AT; Morris CG; Bhatti MT; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1070-7. PubMed ID: 15990010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model.
    Niyazi M; Niemierko A; Paganetti H; Söhn M; Schapira E; Goldberg S; Adams J; Kim V; Oh KS; Hwang WL; Lu HM; Belka C; Busse PM; Loeffler JS; Shih HA
    Radiother Oncol; 2020 Jan; 142():154-161. PubMed ID: 31563411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors.
    Parsons JT; Bova FJ; Fitzgerald CR; Mendenhall WM; Million RR
    Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):755-63. PubMed ID: 7960976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Spot Size and Beam-Shaping Devices on the Treatment Plan Quality for Pencil Beam Scanning Proton Therapy.
    Moteabbed M; Yock TI; Depauw N; Madden TM; Kooy HM; Paganetti H
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):190-198. PubMed ID: 27084640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-Induced Optic Neuropathy: Observation versus Intravitreal Treatment: Can Visual Acuity Be Maintained by Intravitreal Treatment?
    Eckstein D; Riechardt AI; Heufelder J; Zeitz O; Böker A; Brockmann C; Joussen AM; Seibel I
    Am J Ophthalmol; 2019 Dec; 208():289-294. PubMed ID: 31323201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery.
    Leavitt JA; Stafford SL; Link MJ; Pollock BE
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):524-7. PubMed ID: 24074926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
    Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed optic nerve complications after proton beam irradiation.
    Chacko JG; Schatz NJ; Glaser JS
    Ann Ophthalmol (Skokie); 2008; 40(3-4):166-70. PubMed ID: 19230355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy.
    Moiseenko V; Song WY; Mell LK; Bhandare N
    Radiat Oncol; 2011 Jun; 6():61. PubMed ID: 21645390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
    Brodin NP; Kabarriti R; Pankuch M; Schechter CB; Gondi V; Kalnicki S; Guha C; Garg MK; Tomé WA
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):540-552. PubMed ID: 30496877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans.
    Chaikh A; Calugaru V; Bondiau PY; Thariat J; Balosso J
    Int J Radiat Biol; 2018 Sep; 94(9):789-797. PubMed ID: 29878849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.